“Hope for a Cure” Gala event funds clinical trials for rare brain cancer
Charlotte, N.C. (April 27, 2015) – Operation Oligo Cure hosted its second ever “Hope for a Cure” Gala on April 17th at the Elder Gallery in Charlotte, raising $255,000 for targeted brain cancer research. Proceeds from the event are being used to fund promising research and an endowed professorship at the University of Texas MD Anderson Cancer Center in Houston, Texas.
A majority of the event proceeds came from attendees bidding on donated items and experiences at both silent and live auctions. Notable attendees at the gala included North Carolina Senators Thom Tillis and Richard Burr, as well as Dr. Alfred Yung, Chairman of the Neuro-Oncology Department in the Division of Cancer Medicine at MD Anderson.
Operation Oligo Cure is a not-for-profit organization focused on supporting promising brain tumor research specifically targeted to fight Oligodendroglioma (commonly called Oligo), a rare form of brain cancer. “Oligodendroglioma is a very complex tumor,” noted Dr. Yung. “The main reasons for the limited treatment options that exist today are the lack of in-depth understanding of the molecular nature of the tumor, and the lack of culture cells and animal models to study this disease in the laboratory.”
MD Anderson’s Oligo project has two goals. The first is to better understand the molecular drivers of oligodendroglioma growth and progression, and the impact on tumor resistance. The second goal is to establish oligodendroglioma stem cell cultures and tumor models in mice so that new drugs can be identified and treatments can be more personalized for patients of this dreaded disease.
Operation Oligo Cure has raised $1 million since it began fundraising only three years ago and is targeting $5 million by the end of 2016. The “Hope for a Cure” Gala was the Huntersville, N.C. based organization’s second major fundraising event.